Linda Hartman
0000-0003-4583-962X
5 papers found
Refreshing results…
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial
Favourable effect of a ‘second hit’ after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial
Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial
Medication adherence in older people with rheumatoid arthritis is lower according to electronic monitoring than according to pill count
Missing publications? Search for publications with a matching author name.